FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Humira approved for juvenile RA

February 22, 2008 — 7:59am ET
Tools

The FDA has approved Abbott's Humira as a treatment for juvenile rheumatoid arthritis. This marks the sixth approved indication for Abbott's monoclonal antibody. Release

Bookmark and Share
Get Your FREE FierceBiotech Email Newsletter:
Comments (2) | Post a comment
More stories about Humira   FDA   arthritis   Abbott Labs   Rheumatoid Arthritis   monoclonal antibody  

Comments

By Anonymous | Posted 12:10pm | July 1, 2009

The hyperlink to the release of this story is incorrect. Web hosters may want to check into this. Thanks.

By calisha | Posted 12:49pm | July 1, 2009

The link to the release has been corrected. Thanks.

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.